Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis

Studies reported that Serenoa repens was effective in relieving lower urinary tract symptoms (LUTS). This article carried out a systematic review and meta-analysis to compare Serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia (BPH) after at least 6-month treatment cycle....

Full description

Bibliographic Details
Main Authors: Tong Cai, Yuanshan Cui, Shaoxia Yu, Qian Li, Zhongbao Zhou, Zhenli Gao
Format: Article
Language:English
Published: SAGE Publishing 2020-04-01
Series:American Journal of Men's Health
Online Access:https://doi.org/10.1177/1557988320905407
id doaj-fd54a8fb4b224e18bde3dd71e303fe03
record_format Article
spelling doaj-fd54a8fb4b224e18bde3dd71e303fe032020-11-25T03:23:47ZengSAGE PublishingAmerican Journal of Men's Health1557-98912020-04-011410.1177/1557988320905407Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-AnalysisTong Cai0Yuanshan Cui1Shaoxia Yu2Qian Li3Zhongbao Zhou4Zhenli Gao5Tong Cai, Yuanshan Cui, and Shaoxia Yu contributed equally to this work as co-first authorTong Cai, Yuanshan Cui, and Shaoxia Yu contributed equally to this work as co-first authorTong Cai, Yuanshan Cui, and Shaoxia Yu contributed equally to this work as co-first authorDepartment of Research, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, ChinaDepartment of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, ChinaDepartment of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, ChinaStudies reported that Serenoa repens was effective in relieving lower urinary tract symptoms (LUTS). This article carried out a systematic review and meta-analysis to compare Serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia (BPH) after at least 6-month treatment cycle. Four studies involving 1,080 patients (543 in the Serenoa repens group and 537 in the tamsulosin group) were included in the meta-analysis. The results were as follows: compared with tamsulosin, Serenoa repens had a same effect in treating BPH in terms of International Prostate Symptom Score (IPSS) (mean difference [MD] 0.63, 95% confidence interval [CI] [−0.33, 1.59], p = 0.20), quality of life (QoL) (MD 1.51, 95% CI [−1.51, 4.52], p = 0.33), maximum flow rate (Qmax) (MD 0.27, 95% CI [−0.15, 0.68], p = 0.21), postvoid residual volume (PVR) (MD −4.23, 95% CI [−22.97, 14.44], p = 0.65), prostate-specific antigen (PSA) (MD 0.46, 95% CI [−0.06, 0.97], p = 0.08) with the exception of prostate volume (PV) (MD −0.29, 95% CI [−0.41, −0.17], p < 0.00001). For side effects, Serenoa repens was well tolerated compared with tamsulosin especially in ejaculation disorders (odds ratio [OR] = 12.56, 95% CI [3.83, 41.18], p < 0.0001) and decreased libido (OR = 5.40; 95% CI [1.17, 24.87]; p = 0.03). This study indicated that Serenoa repens had the same effect in treating BPH compared with tamsulosin in terms of IPSS, QoL, and PVR after at least 6-month treatment cycle, however, the latter had a greater improvement in PV compared with the former. And Serenoa repens did not increase the risk of adverse events especially with respect to ejaculation disorders and libido decrease.https://doi.org/10.1177/1557988320905407
collection DOAJ
language English
format Article
sources DOAJ
author Tong Cai
Yuanshan Cui
Shaoxia Yu
Qian Li
Zhongbao Zhou
Zhenli Gao
spellingShingle Tong Cai
Yuanshan Cui
Shaoxia Yu
Qian Li
Zhongbao Zhou
Zhenli Gao
Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
American Journal of Men's Health
author_facet Tong Cai
Yuanshan Cui
Shaoxia Yu
Qian Li
Zhongbao Zhou
Zhenli Gao
author_sort Tong Cai
title Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
title_short Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
title_full Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
title_fullStr Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
title_full_unstemmed Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
title_sort comparison of with tamsulosin in the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis
publisher SAGE Publishing
series American Journal of Men's Health
issn 1557-9891
publishDate 2020-04-01
description Studies reported that Serenoa repens was effective in relieving lower urinary tract symptoms (LUTS). This article carried out a systematic review and meta-analysis to compare Serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia (BPH) after at least 6-month treatment cycle. Four studies involving 1,080 patients (543 in the Serenoa repens group and 537 in the tamsulosin group) were included in the meta-analysis. The results were as follows: compared with tamsulosin, Serenoa repens had a same effect in treating BPH in terms of International Prostate Symptom Score (IPSS) (mean difference [MD] 0.63, 95% confidence interval [CI] [−0.33, 1.59], p = 0.20), quality of life (QoL) (MD 1.51, 95% CI [−1.51, 4.52], p = 0.33), maximum flow rate (Qmax) (MD 0.27, 95% CI [−0.15, 0.68], p = 0.21), postvoid residual volume (PVR) (MD −4.23, 95% CI [−22.97, 14.44], p = 0.65), prostate-specific antigen (PSA) (MD 0.46, 95% CI [−0.06, 0.97], p = 0.08) with the exception of prostate volume (PV) (MD −0.29, 95% CI [−0.41, −0.17], p < 0.00001). For side effects, Serenoa repens was well tolerated compared with tamsulosin especially in ejaculation disorders (odds ratio [OR] = 12.56, 95% CI [3.83, 41.18], p < 0.0001) and decreased libido (OR = 5.40; 95% CI [1.17, 24.87]; p = 0.03). This study indicated that Serenoa repens had the same effect in treating BPH compared with tamsulosin in terms of IPSS, QoL, and PVR after at least 6-month treatment cycle, however, the latter had a greater improvement in PV compared with the former. And Serenoa repens did not increase the risk of adverse events especially with respect to ejaculation disorders and libido decrease.
url https://doi.org/10.1177/1557988320905407
work_keys_str_mv AT tongcai comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis
AT yuanshancui comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis
AT shaoxiayu comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis
AT qianli comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis
AT zhongbaozhou comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis
AT zhenligao comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis
_version_ 1724604623186034688